Vireo Growth (VREOF) Other Operating Expenses (2020 - 2026)

Vireo Growth (VREOF) reported Other Operating Expenses of $10.8 million for Q1 2026, up 730.77% on a YoY basis from $1.3 million in Q1 2025, and down 20.28% sequentially from $13.5 million in Q4 2025.

Vireo Growth (VREOF) Other Operating Expenses (2020 - 2026) Analysis & Trends

Vireo Growth (VREOF) has 7 years of Other Operating Expenses data on file, last reported at $10.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Operating Expenses rose 730.77% year-over-year to $10.8 million; the trailing twelve-month figure through Mar 2026 stood at $37.1 million (up 443.1% YoY), and the FY2025 full-year result was $21.9 million, up 900.14% from the prior year.
  • Other Operating Expenses retreated to $10.8 million in Q1 2026, from $13.5 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $13.5 million in Q4 2025 to a low of -$8.6 million in Q4 2022.
  • A 5-year average of $2.0 million and a median of $168359.0 in 2022 frame the typical range for Other Operating Expenses.
  • Across the five-year window, Other Operating Expenses slumped 10958.5% in 2023 and jumped 49411.94% in 2025, its largest moves.
  • Tracing VREOF's Other Operating Expenses over 5 years: stood at -$8.6 million in 2022, then soared by 94.43% to -$478476.0 in 2023, then jumped by 1515.95% to $6.8 million in 2024, then soared by 99.95% to $13.5 million in 2025, then dropped by 20.28% to $10.8 million in 2026.
  • Business Quant data shows VREOF's Other Operating Expenses at $10.8 million in Q1 2026, $13.5 million in Q4 2025, and $6.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.80 Mn
Dec 31, 2025 13.55 Mn
Sep 30, 2025 6.09 Mn
Jun 30, 2025 6.65 Mn
Mar 31, 2025 1.30 Mn
Dec 31, 2024 6.77 Mn
Sep 30, 2024 -12,349.00
Jun 30, 2024 -1.23 Mn
Mar 31, 2024 -887,212.00
Dec 31, 2023 -478,476.00
Sep 30, 2023 -823,400.00
Jun 30, 2023 719,679.00
Mar 31, 2023 386,165.00
Dec 31, 2022 -8.59 Mn
Sep 30, 2022 7,583.00
Jun 30, 2022 -10,930.00
Mar 31, 2022 168,359.00
Dec 31, 2021 6.47 Mn
Mar 31, 2021 437,107.00
Dec 31, 2020 3.37 Mn